发明名称 CONTROLLED RELEASE NUCLEATED TABLET
摘要 Disclosed is a controlled release nucleated tablet which is composed of an inner nucleus and an outer layer that covers the inner nucleus and is capable of maintaining the level of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5- thiazolecarboxylic acid in the blood to a certain value or higher for a long period of time. The controlled release nucleated tablet is characterized in that the inner nucleus contains 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5- thiazolecarboxylic acid and the outer layer contains 2-(3-cyano- 4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and a gel-forming water-soluble polymer that is in an amount of 16 (w/w)% or more relative to the weight of the outer layer.
申请公布号 EP2594269(A4) 申请公布日期 2013.12.04
申请号 EP20110795774 申请日期 2011.06.15
申请人 TEIJIN PHARMA LIMITED 发明人 FUJINAGA, KENTARO;MARUO, SUSUMU;NAKAMURA, HIDEAKI;SUNAGAWA, KENJI;MOCHIZUKI, TSUTOMU;KAGEYAMA, MICHIHARU
分类号 A61K31/426;A61K9/24;A61K9/26;A61K9/28;A61K47/38 主分类号 A61K31/426
代理机构 代理人
主权项
地址